Amerant's Q2 Beat: 0.84% ROA and $9.1B Deposit Target Put the Turnaround Back in Focus

Q2 Results Put Amerant's Turnaround Back in Focus

Amerant's second quarter did not prove a full turnaround, but it made the case harder to dismiss. The company reported diluted EPS of $0.53 versus $0.39 Wall Street estimates, revenue of $100.73 million versus $98.64 million expected, and shares rose 5.3% in after-hours trading to $27.22, still near the stock's 52-week high of $28.17. More importantly, Amerant delivered 0.84% ROA in Q2, a clear step toward management's 1% return-on-assets target.

That matters because the narrative is shifting. After appointing Carlos Iafigliola as president and CEO, the bank is no longer being judged only on stability. One strong quarter is not enough, but it does make the next ones more important. Bulls can point to core deposits grew 9.4% from the prior quarter and additional cost saving initiatives implemented, expected to materialize in 3Q and 4Q. Bears will counter that the balance-sheet growth and cost controls still need to prove they are repeatable.

Low-Cost Deposits Are the Main Driver

The headline beat opened the door, but the more important development was funding. Amerant now has $10.3 billion in total assets and $8.4 billion in deposits after adding $416 million in deposit balances in the quarter. The funding mix also improved: management highlighted international deposit growth, currently yielding under 1%, while management also said results were helped by a $500 million increase in Venezuelan deposits. That combination matters because lower-cost funding is the cleaner way to support loan growth and improve earnings over time.

The income statement is starting to reflect the funding edge

Amerant said Net interest income increased to $82.6 million from $80.3 million, which suggests the cheaper funding was already starting to help results rather than waiting for some future scenario. If deposits stay inexpensive and the bank keeps turning them into earning assets, net interest income has room to keep improving quarter by quarter.

Loan growth is broadening, not concentrating

Gross loans rose by $112 million to $6.9 billion, and management said growth was led by commercial and industrial lending and residential mortgages. That is constructive because it shows the new deposits are being deployed rather than sitting idle. It also fits a more granular credit profile, which matters if the bank wants to avoid leaning too heavily on larger, less liquid commercial real estate exposures.

Credit cleanup is supporting the story

A funding advantage means less if credit keeps creating drag. Amerant said it further optimized the loan portfolio by exiting select exposures, out-of-footprint, and criticized loans, and management also said classified loans declined meaningfully. That does not eliminate execution risk, but it does make the earnings story more credible.

What Has to Hold for AMTB to Keep Rerating

The next quarter needs to turn one strong quarter into a pattern. Management has already guided to about $9.1 billion in deposits by Q4 and about $7.3 billion in total loans by Q4. The real test is whether those targets are reached through stable funding, disciplined credit, and improving operating leverage.

The key signals for the next few quarters

• Deposit growth stays weighted toward lower-cost funding rather than pricier inflows.
• Loan growth continues to lean on commercial and industrial lending and residential mortgages.
• The additional cost saving initiatives start showing up in earnings and help improve the efficiency ratio from 68.37%.
• The deposit bridge remains credible on the way toward about $9.1 billion in deposits by Q4.

If those boxes stay green, the market has a concrete reason to keep paying attention. If funding gets more expensive, savings slip, or credit quality weakens, the rerating case weakens quickly.

Why the Next Earnings Report Matters More Than This One

Amerant's Q2 was strong enough to bring the turnaround story back into focus, but not strong enough to end the debate. The combination of 0.84% ROA in Q2, healthier deposit growth, and management's year-end balance-sheet targets is compelling. What investors need next is proof that these improvements can compound rather than fade after one quarter.